https://www.epo.org/fr/boards-of-appeal/decisions/t050433eu1
T 0433/05 (Fusion Peptide Inhibitors/CONJUCHEM) du 14.06.2007
fusion peptide043305
https://www.jci.org/assets/235116/powerpoint
JCI - HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation
https://elifesciences.org/articles/64507
A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis...
The mechanism triggering HBV membrane fusion involves ERp57, a cellular protein disulfide isomerase, and ultimately leads to the exposition of a fusion peptide...
https://www.ncbi.nlm.nih.gov/Structure/pdb/7E43
7E43: Structural insights into a bifunctional peptide methionine sulfoxide reductase MsrA/B fusion...
Peptide methionine sulfoxide reductase MsrA/MsrBACETATE ION
https://www.mdpi.com/1422-0067/22/10/5301
Transient Excursions to Membrane Core as Determinants of Influenza Virus Fusion Peptide Activity
Fusion of viral and host cell membranes is a critical step in the life cycle of enveloped viruses. In the case of influenza virus, it is mediated by subunit 2...
https://pmc.ncbi.nlm.nih.gov/articles/PMC47480/
Processing of a fusion protein by endoprotease in COS-1 cells for secretion of mature peptide by...
The subtilisin-related proprotein convertase furin is expressed in various mammalian tissues. Expecting that COS-1 cells have a furin-like endoprotease, we...
https://www.ncbi.nlm.nih.gov/Structure/pdb/2L6T
2L6T: Efficacy of an HIV-1 entry inhibitor targeting the GP41 fusion peptide
https://www.rcsb.org/structure/7SL5
RCSB PDB - 7SL5: Crystal Structure of VP12E7 Fab in complex with SARS-CoV-2 S fusion peptide
Crystal Structure of VP12E7 Fab in complex with SARS-CoV-2 S fusion peptide
https://pmc.ncbi.nlm.nih.gov/articles/PMC11007196/
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide...
The DNAJB1-PRKACA fusion transcript was identified as the oncogenic driver of tumor pathogenesis in fibrolamellar hepatocellular carcinoma (FL-HCC), also known...
phase i clinical trial